InvestorsObserver
×
News Home

Should Biotechnology Stock KALA BIO Inc (KALA) Be in Your Portfolio Wednesday?

Wednesday, December 06, 2023 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock KALA BIO Inc (KALA) Be in Your Portfolio Wednesday?

A rating of 82 puts KALA BIO Inc (KALA) near the top of the Biotechnology industry according to InvestorsObserver. KALA BIO Inc's score of 82 means it scores higher than 82% of stocks in the industry. KALA BIO Inc also received an overall rating of 63, putting it above 63% of all stocks. Biotechnology is ranked 50 out of the 148 industries.

Overall Score - 63
KALA has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on KALA!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With KALA BIO Inc Stock Today?

KALA BIO Inc (KALA) stock has fallen -3.14% while the S&P 500 is higher by 0.22% as of 10:44 AM on Wednesday, Dec 6. KALA has fallen -$0.28 from the previous closing price of $8.91 on volume of 169,577 shares. Over the past year the S&P 500 has risen 16.13% while KALA is higher by 75.76%. KALA lost -$22.73 per share the over the last 12 months. Click Here to get the full Stock Report for KALA BIO Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App